mTOR

Rapamycin – the most promising life extension drug?

Biotech Features

Longevity treatments do not slow aging

Innovation

Dr Robert Lufkin: It’s time to tackle the longevity lie

Economy Features

Combination therapy could delay sarcopenia-related muscle loss

Innovation

New mTOR player storms into longevity

Biotech Features

Next gen rapalogs – Cambrian Biopharma announces mTOR inhibitors licensing agreement

Biotech Investment